Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
---|
08/16/2007 | US20070191410 Cyclopamine analogues and methods of use thereof |
08/16/2007 | US20070191379 ABCA1 elevating compounds |
08/16/2007 | US20070191373 Heterocyclic compounds for use in the treatment of viral infections |
08/16/2007 | US20070191339 Crystalline forms of a pharmaceutical compound |
08/16/2007 | US20070191334 Tricyclic imidazopyridines |
08/16/2007 | US20070190523 Method and compositions for identifying anti-hiv therapeutic compounds |
08/16/2007 | CA2640652A1 Novel coumarin derivative having antitumor activity |
08/15/2007 | EP1817310A1 (spirocyclylamido) aminothiophene compounds as c-kit proto-oncogene inhibitors |
08/15/2007 | EP1817288A1 Dual antiplatelet/anticoagulant pyridoxine analogs |
08/15/2007 | EP1817036A2 Modulators of muscarinic receptors |
08/15/2007 | EP1534715B1 Furopyridine and furopyrimidine derivatives for the treatment of hyper-proliferative disorders |
08/15/2007 | EP1458724B1 Total synthesis of galanthamine, analogues and derivatives thereof |
08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
08/14/2007 | US7256293 Imidazopyridine intermediates |
08/14/2007 | US7256187 E.g., 11-Dideoxy-4,11-dihydroxyiminorifamycin S and (R/S)-3-[4-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-2-methyl-piperazin-1-yl-aminomethylenyl]-11-deoxy-11-hydroxyiminorifamycin SV; especially effective against rifamycin-resistant microbes |
08/14/2007 | US7256158 Animal husbandry; veterinary medicine |
08/09/2007 | WO2007089683A1 Amido compounds and their use as pharmaceuticals |
08/09/2007 | WO2007089018A1 Triazole derivative |
08/09/2007 | WO2007088462A1 Spirochromane antagonists of the h-3 receptor |
08/09/2007 | WO2007088148A1 Derivatives of thiophene carboxilic acid as antiviral agent |
08/09/2007 | US20070185153 Compounds |
08/09/2007 | US20070185144 N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((4S)-2,6,6-trimethyl-4,5,6,7-tetrahydro-1-benzofuran-4yl)amino)propyl)acetamide, used for the treatment of Alzheimer's disease and conditions involving amyloid deposits on the brain |
08/09/2007 | US20070185131 Heterocyclic Compounds |
08/09/2007 | US20070185120 (4-Methyl-piperazin-1-yl)-(6H-thieno[2,3-b]pyrrol-5-yl)-methanone; (2,3-Dichloro-6H-thieno[2,3-b]pyrrol-5-yl)-(4-methyl-piperazin-1-yl)-methanone; histamine H4 receptor antagonist; treats allergic rhinitis |
08/09/2007 | US20070185104 Benzoxazole acetonitriles |
08/09/2007 | US20070185098 antiinflammatory agents, anticarcinogenic agents; 1-(5-tert-Butyl-3-(thiomorpholine-1,1-dioxide-4-carbonyl)thiophen-2-yl)-3-(3',4'-difluoro[1,1'-biphenyl]urea; enzyme inhibitors |
08/09/2007 | US20070185094 Novel 3-substitued-1,4-benzodiazepines |
08/09/2007 | US20070185087 Compounds and methods for inhibiting mitotic progression |
08/09/2007 | CA2635814A1 Amido compounds and their use as pharmaceuticals |
08/08/2007 | EP1506202B1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
08/08/2007 | EP1069127B1 Microencapsulated lewis acid |
08/08/2007 | CN101014603A Compounds and methods for inhibiting mitotic progression by ingibiting aurora kinase |
08/08/2007 | CN101012229A Hanfangchin A without benzene and chloroform and preparing method thereof |
08/08/2007 | CN101012196A Fragrant geldanamycin derivative and its preparing method and use |
08/07/2007 | US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
08/07/2007 | US7253205 Neurokinin 1 (NK-1) receptor antagonists; depression, anxiety, pain, inflammation, migraine, emesis, postherpetic neuralgia |
08/07/2007 | US7253203 Indoline derivatives |
08/07/2007 | US7253180 Viricides; immunology moderator |
08/07/2007 | US7253177 Synthesis and antimalarial activity of pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives |
08/07/2007 | CA2302943C Phthalazine compounds and therapeutic agents for erectile dysfunction |
08/02/2007 | WO2007087204A2 Heterocycles as nicotinic acid receptor agonists for the treatment of dyyslipidemia |
08/02/2007 | WO2007076127A3 Condensed imidazoles or pyrazoles and their use as transforming growth factor modulators |
08/02/2007 | WO2007016979A3 NOVEL HETEROCYCLIC NF-κB INHIBITORS |
08/02/2007 | US20070179167 Inhibitors of serine proteases |
08/02/2007 | US20070179142 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
08/02/2007 | US20070179129 Opioid receptor antagonists |
08/02/2007 | CA2637717A1 Heterocycles as nicotinic acid receptor agonists for the treatment of dyyslipidemia |
08/01/2007 | EP1813617A1 PROCESS FOR PRODUCING BENZOÝc¨PHENANTHRIDINE DERIVATIVE |
08/01/2007 | EP1813616A2 Pyrazoloquinolines with immunomodulating activity |
08/01/2007 | EP1812443A2 [3.2.0] heterocyclic compounds and methods of using the same |
08/01/2007 | EP1812404A1 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents |
08/01/2007 | EP1812113A1 Pyrimidine compounds as histamine modulators |
08/01/2007 | EP1487822B1 Pyrrole-2,5-dione derivatives and their use as gsk-3 inhibitors |
08/01/2007 | EP1255759B1 Synthetic process for an intermediate for ecteinascidin and phthalascidin compounds |
08/01/2007 | CN1329395C Tricyclic imidazopyridines |
08/01/2007 | CN101008023A Technology for extracting dihydrogalanthamine from lycoris radiata genus plant |
08/01/2007 | CN101007809A Water-soluble camptothecine derivative and its preparation process and application thereof |
08/01/2007 | CN101007808A Process for preparing superfine camptothecine |
08/01/2007 | CN101007807A 6-cyano-1,1(1,3-subpropyldioxy)-7-[1'-(carbalkoxy)-propyl]-5-oxo-delta6(8)-tetrahydro indolizine compound preparation method |
07/31/2007 | USRE39754 Benzamide derivatives and pharmaceutical compositions containing same |
07/31/2007 | US7250438 Anti-bacterial and anti-cancer spiro beta-lactone/gamma-lactams |
07/31/2007 | US7250426 acid addition salt of optionally substituted 5-[2-(indan-2-ylamino-1-hydroxyethyl)]-8-hydroxyquinolone; treating respiratory disorders, especially asthma and COPD |
07/31/2007 | US7250424 Fab I inhibitors |
07/31/2007 | US7250423 Methods for synthesizing heterocycles and therapeutic use of the heterocycles for cancers |
07/31/2007 | US7250413 C-25 carbamate rifamycin derivatives with activity against drug-resistant microbes |
07/31/2007 | US7250410 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof |
07/31/2007 | US7250409 Ningalin B analogs employable for reversing multidrug resistance |
07/31/2007 | CA2215633C Oxidative process for preparing narwedine derivatives |
07/26/2007 | WO2007084455A1 Hydantoin compounds for the treatment of inflammatory disorders |
07/26/2007 | WO2007040650A9 Apoptosis promoters |
07/26/2007 | WO2007021674A3 Method of acylating maytansinol with chiral amino acids |
07/26/2007 | WO2006127588A3 Modulators of atp-binding cassette transporters |
07/26/2007 | US20070173642 Process for the purification of macrolides |
07/26/2007 | US20070173640 Ionic liquid type crown ether derivatives, method for preparing the same and method for isolating metal ions using the same |
07/26/2007 | US20070173570 polystyrene polymerization activator; 7,7,9,9-Tetramethyl-8-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,4-dioxa-8-aza-spiro[4.5]decane; or 3,3,8,8,10,10-Hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza -spiro[5.5]undecane |
07/26/2007 | US20070173507 Dairyl-substituted five-membered heterocycle derivative |
07/26/2007 | US20070173495 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia |
07/26/2007 | US20070172951 Time-temperature indicator based on valence isomerizations |
07/26/2007 | US20070172420 Ligands |
07/26/2007 | CA2637385A1 Compounds for the treatment of inflammatory disorders |
07/26/2007 | CA2637198A1 Hydantoin compounds for the treatment of inflammatory disorders |
07/25/2007 | EP1809635A1 2,6-diethyl-4-methyl-phenyl-substituted tetramic acid derivatives |
07/25/2007 | EP1809634A1 2-alkoxy-6-alkyl-phenyl-substituted spirocyclic tetramic acid derivatives |
07/25/2007 | EP1809605A1 Quinoline as allosteric enhancers of the gaba-b receptors |
07/25/2007 | CN101006055A 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase iepsilon |
07/25/2007 | CN101005840A Process to prepare camptothecin derivatives and novel intermediate and compounds thereof |
07/25/2007 | CN101003556A Derivative of 10 ¿C hydroxyl camptothecin, prepartion of its liposome, and preparation method |
07/25/2007 | CN101003538A [1,4]diazocino[7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents |
07/25/2007 | CN101003515A 4-anilino quinazoline derivatives as antiproliferative agents |
07/24/2007 | US7247756 1,4-disubstituted benzenes as insecticides |
07/24/2007 | US7247648 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones |
07/24/2007 | US7247634 Rifamycin derivatives effective against drug-resistant microbes |
07/24/2007 | US7247629 Antitumoral analogs of et-743 |
07/24/2007 | US7247628 Cannabinoid receptor ligands and uses thereof |
07/24/2007 | CA2311476C Dibenzorhodamine dyes useful as florescent labelling agents |
07/19/2007 | WO2007081690A2 Inhibitors of protein kinases |
07/19/2007 | WO2007079862A1 Novel, acyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases |
07/19/2007 | WO2007079861A1 Novel, cyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases |
07/19/2007 | WO2007079830A1 Oxaphenanthrene derivatives |
07/19/2007 | US20070167451 BARBITURIC ACID DERIVATIVES AS INHIBITORS OF TNF-alpha CONVERTING ENZYME (TACE) AND/OR MATRIX METALLOPROTEINASES |